IBDEI00M ; ; 01-AUG-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,935,0)
;;=C22.0^^10^71^4
;;^UTILITY(U,$J,358.3,935,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,935,1,3,0)
;;=3^Liver cell carcinoma
;;^UTILITY(U,$J,358.3,935,1,4,0)
;;=4^C22.0
;;^UTILITY(U,$J,358.3,935,2)
;;=^5000933
;;^UTILITY(U,$J,358.3,936,0)
;;=C22.4^^10^71^19
;;^UTILITY(U,$J,358.3,936,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,936,1,3,0)
;;=3^Sarcomas of Liver NEC
;;^UTILITY(U,$J,358.3,936,1,4,0)
;;=4^C22.4
;;^UTILITY(U,$J,358.3,936,2)
;;=^5000937
;;^UTILITY(U,$J,358.3,937,0)
;;=C22.3^^10^71^1
;;^UTILITY(U,$J,358.3,937,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,937,1,3,0)
;;=3^Angiosarcoma of liver
;;^UTILITY(U,$J,358.3,937,1,4,0)
;;=4^C22.3
;;^UTILITY(U,$J,358.3,937,2)
;;=^5000936
;;^UTILITY(U,$J,358.3,938,0)
;;=C23.^^10^71^11
;;^UTILITY(U,$J,358.3,938,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,938,1,3,0)
;;=3^Malignant neoplasm of gallbladder
;;^UTILITY(U,$J,358.3,938,1,4,0)
;;=4^C23.
;;^UTILITY(U,$J,358.3,938,2)
;;=^267098
;;^UTILITY(U,$J,358.3,939,0)
;;=C24.0^^10^71^10
;;^UTILITY(U,$J,358.3,939,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,939,1,3,0)
;;=3^Malignant neoplasm of extrahepatic bile duct
;;^UTILITY(U,$J,358.3,939,1,4,0)
;;=4^C24.0
;;^UTILITY(U,$J,358.3,939,2)
;;=^5000940
;;^UTILITY(U,$J,358.3,940,0)
;;=C24.1^^10^71^5
;;^UTILITY(U,$J,358.3,940,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,940,1,3,0)
;;=3^Malignant neoplasm of ampulla of Vater
;;^UTILITY(U,$J,358.3,940,1,4,0)
;;=4^C24.1
;;^UTILITY(U,$J,358.3,940,2)
;;=^267100
;;^UTILITY(U,$J,358.3,941,0)
;;=C25.9^^10^71^14
;;^UTILITY(U,$J,358.3,941,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,941,1,3,0)
;;=3^Malignant neoplasm of pancreas, unspecified
;;^UTILITY(U,$J,358.3,941,1,4,0)
;;=4^C25.9
;;^UTILITY(U,$J,358.3,941,2)
;;=^5000946
;;^UTILITY(U,$J,358.3,942,0)
;;=C19.^^10^71^15
;;^UTILITY(U,$J,358.3,942,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,942,1,3,0)
;;=3^Malignant neoplasm of rectosigmoid junction
;;^UTILITY(U,$J,358.3,942,1,4,0)
;;=4^C19.
;;^UTILITY(U,$J,358.3,942,2)
;;=^267089
;;^UTILITY(U,$J,358.3,943,0)
;;=C24.8^^10^71^13
;;^UTILITY(U,$J,358.3,943,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,943,1,3,0)
;;=3^Malignant neoplasm of overlapping sites of biliary tract
;;^UTILITY(U,$J,358.3,943,1,4,0)
;;=4^C24.8
;;^UTILITY(U,$J,358.3,943,2)
;;=^5000941
;;^UTILITY(U,$J,358.3,944,0)
;;=C24.9^^10^71^7
;;^UTILITY(U,$J,358.3,944,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,944,1,3,0)
;;=3^Malignant neoplasm of biliary tract,unspec
;;^UTILITY(U,$J,358.3,944,1,4,0)
;;=4^C24.9
;;^UTILITY(U,$J,358.3,944,2)
;;=^5000942
;;^UTILITY(U,$J,358.3,945,0)
;;=C01.^^10^72^2
;;^UTILITY(U,$J,358.3,945,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,945,1,3,0)
;;=3^Malignant neoplasm of base of tongue
;;^UTILITY(U,$J,358.3,945,1,4,0)
;;=4^C01.
;;^UTILITY(U,$J,358.3,945,2)
;;=^266996
;;^UTILITY(U,$J,358.3,946,0)
;;=C02.9^^10^72^17
;;^UTILITY(U,$J,358.3,946,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,946,1,3,0)
;;=3^Malignant neoplasm of tongue, unspecified
;;^UTILITY(U,$J,358.3,946,1,4,0)
;;=4^C02.9
;;^UTILITY(U,$J,358.3,946,2)
;;=^5000891
;;^UTILITY(U,$J,358.3,947,0)
;;=C04.9^^10^72^3
;;^UTILITY(U,$J,358.3,947,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,947,1,3,0)
;;=3^Malignant neoplasm of floor of mouth, unspecified
;;^UTILITY(U,$J,358.3,947,1,4,0)
;;=4^C04.9
;;^UTILITY(U,$J,358.3,947,2)
;;=^5000896
;;^UTILITY(U,$J,358.3,948,0)
;;=C06.9^^10^72^8
;;^UTILITY(U,$J,358.3,948,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,948,1,3,0)
;;=3^Malignant neoplasm of mouth, unspecified
;;^UTILITY(U,$J,358.3,948,1,4,0)
;;=4^C06.9
;;^UTILITY(U,$J,358.3,948,2)
;;=^5000901
;;^UTILITY(U,$J,358.3,949,0)
;;=C10.9^^10^72^10
;;^UTILITY(U,$J,358.3,949,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,949,1,3,0)
;;=3^Malignant neoplasm of oropharynx, unspecified
;;^UTILITY(U,$J,358.3,949,1,4,0)
;;=4^C10.9
;;^UTILITY(U,$J,358.3,949,2)
;;=^5000909
;;^UTILITY(U,$J,358.3,950,0)
;;=C11.9^^10^72^9
;;^UTILITY(U,$J,358.3,950,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,950,1,3,0)
;;=3^Malignant neoplasm of nasopharynx, unspecified
;;^UTILITY(U,$J,358.3,950,1,4,0)
;;=4^C11.9
;;^UTILITY(U,$J,358.3,950,2)
;;=^5000911
;;^UTILITY(U,$J,358.3,951,0)
;;=C31.9^^10^72^1
;;^UTILITY(U,$J,358.3,951,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,951,1,3,0)
;;=3^Malignant neoplasm of accessory sinus, unspecified
;;^UTILITY(U,$J,358.3,951,1,4,0)
;;=4^C31.9
;;^UTILITY(U,$J,358.3,951,2)
;;=^5000953
;;^UTILITY(U,$J,358.3,952,0)
;;=C32.9^^10^72^6
;;^UTILITY(U,$J,358.3,952,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,952,1,3,0)
;;=3^Malignant neoplasm of larynx, unspecified
;;^UTILITY(U,$J,358.3,952,1,4,0)
;;=4^C32.9
;;^UTILITY(U,$J,358.3,952,2)
;;=^5000956
;;^UTILITY(U,$J,358.3,953,0)
;;=C33.^^10^72^19
;;^UTILITY(U,$J,358.3,953,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,953,1,3,0)
;;=3^Malignant neoplasm of trachea
;;^UTILITY(U,$J,358.3,953,1,4,0)
;;=4^C33.
;;^UTILITY(U,$J,358.3,953,2)
;;=^267135
;;^UTILITY(U,$J,358.3,954,0)
;;=C34.91^^10^72^21
;;^UTILITY(U,$J,358.3,954,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,954,1,3,0)
;;=3^Malignant neoplasm of unsp part of right bronchus or lung
;;^UTILITY(U,$J,358.3,954,1,4,0)
;;=4^C34.91
;;^UTILITY(U,$J,358.3,954,2)
;;=^5000967
;;^UTILITY(U,$J,358.3,955,0)
;;=C34.92^^10^72^20
;;^UTILITY(U,$J,358.3,955,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,955,1,3,0)
;;=3^Malignant neoplasm of unsp part of left bronchus or lung
;;^UTILITY(U,$J,358.3,955,1,4,0)
;;=4^C34.92
;;^UTILITY(U,$J,358.3,955,2)
;;=^5000968
;;^UTILITY(U,$J,358.3,956,0)
;;=C38.4^^10^72^14
;;^UTILITY(U,$J,358.3,956,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,956,1,3,0)
;;=3^Malignant neoplasm of pleura
;;^UTILITY(U,$J,358.3,956,1,4,0)
;;=4^C38.4
;;^UTILITY(U,$J,358.3,956,2)
;;=^267140
;;^UTILITY(U,$J,358.3,957,0)
;;=C45.0^^10^72^22
;;^UTILITY(U,$J,358.3,957,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,957,1,3,0)
;;=3^Mesothelioma of pleura
;;^UTILITY(U,$J,358.3,957,1,4,0)
;;=4^C45.0
;;^UTILITY(U,$J,358.3,957,2)
;;=^5001095
;;^UTILITY(U,$J,358.3,958,0)
;;=C73.^^10^72^16
;;^UTILITY(U,$J,358.3,958,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,958,1,3,0)
;;=3^Malignant neoplasm of thyroid gland
;;^UTILITY(U,$J,358.3,958,1,4,0)
;;=4^C73.
;;^UTILITY(U,$J,358.3,958,2)
;;=^267296
;;^UTILITY(U,$J,358.3,959,0)
;;=C76.0^^10^72^4
;;^UTILITY(U,$J,358.3,959,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,959,1,3,0)
;;=3^Malignant neoplasm of head, face and neck
;;^UTILITY(U,$J,358.3,959,1,4,0)
;;=4^C76.0
;;^UTILITY(U,$J,358.3,959,2)
;;=^5001324
;;^UTILITY(U,$J,358.3,960,0)
;;=C05.9^^10^72^11
;;^UTILITY(U,$J,358.3,960,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,960,1,3,0)
;;=3^Malignant neoplasm of palate,unspec
;;^UTILITY(U,$J,358.3,960,1,4,0)
;;=4^C05.9
;;^UTILITY(U,$J,358.3,960,2)
;;=^5000898
;;^UTILITY(U,$J,358.3,961,0)
;;=C07.^^10^72^12
;;^UTILITY(U,$J,358.3,961,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,961,1,3,0)
;;=3^Malignant neoplasm of parotid gland
;;^UTILITY(U,$J,358.3,961,1,4,0)
;;=4^C07.
;;^UTILITY(U,$J,358.3,961,2)
;;=^267005
;;^UTILITY(U,$J,358.3,962,0)
;;=C08.9^^10^72^7
;;^UTILITY(U,$J,358.3,962,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,962,1,3,0)
;;=3^Malignant neoplasm of major salivary gland,unspec
;;^UTILITY(U,$J,358.3,962,1,4,0)
;;=4^C08.9
;;^UTILITY(U,$J,358.3,962,2)
;;=^5000902
;;^UTILITY(U,$J,358.3,963,0)
;;=C09.9^^10^72^18
;;^UTILITY(U,$J,358.3,963,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,963,1,3,0)
;;=3^Malignant neoplasm of tonsil,unspec
;;^UTILITY(U,$J,358.3,963,1,4,0)
;;=4^C09.9
;;^UTILITY(U,$J,358.3,963,2)
;;=^5000905
;;^UTILITY(U,$J,358.3,964,0)
;;=C12.^^10^72^15
;;^UTILITY(U,$J,358.3,964,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,964,1,3,0)
;;=3^Malignant neoplasm of pyriform sinus
;;^UTILITY(U,$J,358.3,964,1,4,0)
;;=4^C12.
;;^UTILITY(U,$J,358.3,964,2)
;;=^267046
;;^UTILITY(U,$J,358.3,965,0)
;;=C13.9^^10^72^5
;;^UTILITY(U,$J,358.3,965,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,965,1,3,0)
;;=3^Malignant neoplasm of hypopharynx,unspec
;;^UTILITY(U,$J,358.3,965,1,4,0)
;;=4^C13.9
;;^UTILITY(U,$J,358.3,965,2)
;;=^5000915
;;^UTILITY(U,$J,358.3,966,0)
;;=C14.0^^10^72^13
;;^UTILITY(U,$J,358.3,966,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,966,1,3,0)
;;=3^Malignant neoplasm of pharynx,unspec
;;^UTILITY(U,$J,358.3,966,1,4,0)
;;=4^C14.0
;;^UTILITY(U,$J,358.3,966,2)
;;=^5000916
;;^UTILITY(U,$J,358.3,967,0)
;;=D57.40^^10^73^15
;;^UTILITY(U,$J,358.3,967,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,967,1,3,0)
;;=3^Sickle-cell thalassemia without crisis
;;^UTILITY(U,$J,358.3,967,1,4,0)
;;=4^D57.40
;;^UTILITY(U,$J,358.3,967,2)
;;=^329908
;;^UTILITY(U,$J,358.3,968,0)
;;=D57.419^^10^73^14
;;^UTILITY(U,$J,358.3,968,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,968,1,3,0)
;;=3^Sickle-cell thalassemia with crisis, unspecified
;;^UTILITY(U,$J,358.3,968,1,4,0)
;;=4^D57.419
;;^UTILITY(U,$J,358.3,968,2)
;;=^5002316
;;^UTILITY(U,$J,358.3,969,0)
;;=D56.0^^10^73^1
;;^UTILITY(U,$J,358.3,969,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,969,1,3,0)
;;=3^Alpha thalassemia
;;^UTILITY(U,$J,358.3,969,1,4,0)
;;=4^D56.0
;;^UTILITY(U,$J,358.3,969,2)
;;=^340494
;;^UTILITY(U,$J,358.3,970,0)
;;=D56.1^^10^73^2
;;^UTILITY(U,$J,358.3,970,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,970,1,3,0)
;;=3^Beta thalassemia
;;^UTILITY(U,$J,358.3,970,1,4,0)
;;=4^D56.1
;;^UTILITY(U,$J,358.3,970,2)
;;=^340495
;;^UTILITY(U,$J,358.3,971,0)
;;=D56.2^^10^73^3
;;^UTILITY(U,$J,358.3,971,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,971,1,3,0)
;;=3^Delta-beta thalassemia
;;^UTILITY(U,$J,358.3,971,1,4,0)
;;=4^D56.2
;;^UTILITY(U,$J,358.3,971,2)
;;=^340496
;;^UTILITY(U,$J,358.3,972,0)
;;=D56.3^^10^73^18
;;^UTILITY(U,$J,358.3,972,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,972,1,3,0)
;;=3^Thalassemia minor
;;^UTILITY(U,$J,358.3,972,1,4,0)
;;=4^D56.3
;;^UTILITY(U,$J,358.3,972,2)
;;=^340497
;;^UTILITY(U,$J,358.3,973,0)
;;=D56.5^^10^73^7
;;^UTILITY(U,$J,358.3,973,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,973,1,3,0)
;;=3^Hemoglobin E-beta thalassemia
;;^UTILITY(U,$J,358.3,973,1,4,0)
;;=4^D56.5
;;^UTILITY(U,$J,358.3,973,2)
;;=^340498
;;^UTILITY(U,$J,358.3,974,0)
;;=D56.8^^10^73^19
;;^UTILITY(U,$J,358.3,974,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,974,1,3,0)
;;=3^Thalassemias NEC
;;^UTILITY(U,$J,358.3,974,1,4,0)
;;=4^D56.8
;;^UTILITY(U,$J,358.3,974,2)
;;=^5002305
;;^UTILITY(U,$J,358.3,975,0)
;;=D57.3^^10^73^16
;;^UTILITY(U,$J,358.3,975,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,975,1,3,0)
;;=3^Sickle-cell trait
;;^UTILITY(U,$J,358.3,975,1,4,0)
;;=4^D57.3
;;^UTILITY(U,$J,358.3,975,2)
;;=^5002313
;;^UTILITY(U,$J,358.3,976,0)
;;=D57.1^^10^73^13
;;^UTILITY(U,$J,358.3,976,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,976,1,3,0)
;;=3^Sickle-cell disease without crisis
;;^UTILITY(U,$J,358.3,976,1,4,0)
;;=4^D57.1
;;^UTILITY(U,$J,358.3,976,2)
;;=^5002309
;;^UTILITY(U,$J,358.3,977,0)
;;=D57.02^^10^73^6
;;^UTILITY(U,$J,358.3,977,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,977,1,3,0)
;;=3^Hb-SS disease with splenic sequestration
;;^UTILITY(U,$J,358.3,977,1,4,0)
;;=4^D57.02
;;^UTILITY(U,$J,358.3,977,2)
;;=^5002308
;;^UTILITY(U,$J,358.3,978,0)
;;=D57.01^^10^73^4
;;^UTILITY(U,$J,358.3,978,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,978,1,3,0)
;;=3^Hb-SS disease with acute chest syndrome
;;^UTILITY(U,$J,358.3,978,1,4,0)
;;=4^D57.01
;;^UTILITY(U,$J,358.3,978,2)
;;=^5002307
;;^UTILITY(U,$J,358.3,979,0)
;;=D57.00^^10^73^5
;;^UTILITY(U,$J,358.3,979,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,979,1,3,0)
;;=3^Hb-SS disease with crisis, unspecified
;;^UTILITY(U,$J,358.3,979,1,4,0)
;;=4^D57.00
;;^UTILITY(U,$J,358.3,979,2)
;;=^5002306
;;^UTILITY(U,$J,358.3,980,0)
;;=D57.20^^10^73^17
;;^UTILITY(U,$J,358.3,980,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,980,1,3,0)
;;=3^Sickle-cell/Hb-C disease without crisis
;;^UTILITY(U,$J,358.3,980,1,4,0)
;;=4^D57.20
;;^UTILITY(U,$J,358.3,980,2)
;;=^330080
;;^UTILITY(U,$J,358.3,981,0)
;;=D57.811^^10^73^10
;;^UTILITY(U,$J,358.3,981,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,981,1,3,0)
;;=3^Sickle-Cell Disorders w/ Acute Chest Syndrome NEC
;;^UTILITY(U,$J,358.3,981,1,4,0)
;;=4^D57.811
;;^UTILITY(U,$J,358.3,981,2)
;;=^5002318
;;^UTILITY(U,$J,358.3,982,0)
;;=D57.812^^10^73^11
;;^UTILITY(U,$J,358.3,982,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,982,1,3,0)
;;=3^Sickle-Cell Disorders w/ Splenic Sequestration
;;^UTILITY(U,$J,358.3,982,1,4,0)
;;=4^D57.812
;;^UTILITY(U,$J,358.3,982,2)
;;=^5002319
;;^UTILITY(U,$J,358.3,983,0)
;;=D57.819^^10^73^12
;;^UTILITY(U,$J,358.3,983,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,983,1,3,0)
;;=3^Sickle-Cell Disorders w/ Unspec Crisis NEC
;;^UTILITY(U,$J,358.3,983,1,4,0)
;;=4^D57.819
;;^UTILITY(U,$J,358.3,983,2)
;;=^5002320
;;^UTILITY(U,$J,358.3,984,0)
;;=D58.8^^10^73^9
;;^UTILITY(U,$J,358.3,984,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,984,1,3,0)
;;=3^Hereditary Hemolytic Anemias NEC
;;^UTILITY(U,$J,358.3,984,1,4,0)
;;=4^D58.8
;;^UTILITY(U,$J,358.3,984,2)
;;=^267984
;;^UTILITY(U,$J,358.3,985,0)
;;=D58.2^^10^73^8
;;^UTILITY(U,$J,358.3,985,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,985,1,3,0)
;;=3^Hemoglobinopathies NEC
;;^UTILITY(U,$J,358.3,985,1,4,0)
;;=4^D58.2
;;^UTILITY(U,$J,358.3,985,2)
;;=^87629
;;^UTILITY(U,$J,358.3,986,0)
;;=C83.10^^10^74^52
;;^UTILITY(U,$J,358.3,986,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,986,1,3,0)
;;=3^Mantle cell lymphoma, unspecified site
;;^UTILITY(U,$J,358.3,986,1,4,0)
;;=4^C83.10
;;^UTILITY(U,$J,358.3,986,2)
;;=^5001561
;;^UTILITY(U,$J,358.3,987,0)
;;=C83.19^^10^74^51
;;^UTILITY(U,$J,358.3,987,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,987,1,3,0)
;;=3^Mantle cell lymphoma, extranodal and solid organ sites
;;^UTILITY(U,$J,358.3,987,1,4,0)
;;=4^C83.19
;;^UTILITY(U,$J,358.3,987,2)
;;=^5001570
;;^UTILITY(U,$J,358.3,988,0)
;;=C83.50^^10^74^45
;;^UTILITY(U,$J,358.3,988,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,988,1,3,0)
;;=3^Lymphoblastic (diffuse) lymphoma, unspecified site
;;^UTILITY(U,$J,358.3,988,1,4,0)
;;=4^C83.50
;;^UTILITY(U,$J,358.3,988,2)
;;=^5001581
;;^UTILITY(U,$J,358.3,989,0)
;;=C83.59^^10^74^46
;;^UTILITY(U,$J,358.3,989,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,989,1,3,0)
;;=3^Lymphoblastic lymphoma, extrnod and solid organ sites
;;^UTILITY(U,$J,358.3,989,1,4,0)
;;=4^C83.59
;;^UTILITY(U,$J,358.3,989,2)
;;=^5001590
;;^UTILITY(U,$J,358.3,990,0)
;;=C83.70^^10^74^12
;;^UTILITY(U,$J,358.3,990,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,990,1,3,0)
;;=3^Burkitt lymphoma, unspecified site
;;^UTILITY(U,$J,358.3,990,1,4,0)
;;=4^C83.70
;;^UTILITY(U,$J,358.3,990,2)
;;=^5001591
;;^UTILITY(U,$J,358.3,991,0)
;;=C83.79^^10^74^11
;;^UTILITY(U,$J,358.3,991,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,991,1,3,0)
;;=3^Burkitt lymphoma, extranodal and solid organ sites
;;^UTILITY(U,$J,358.3,991,1,4,0)
;;=4^C83.79
;;^UTILITY(U,$J,358.3,991,2)
;;=^5001600
;;^UTILITY(U,$J,358.3,992,0)
;;=C81.00^^10^74^61
;;^UTILITY(U,$J,358.3,992,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,992,1,3,0)
;;=3^Nodular lymphocyte predominant Hodgkin lymphoma, unsp site
;;^UTILITY(U,$J,358.3,992,1,4,0)
;;=4^C81.00
;;^UTILITY(U,$J,358.3,992,2)
;;=^5001391
;;^UTILITY(U,$J,358.3,993,0)
;;=C83.39^^10^74^22
;;^UTILITY(U,$J,358.3,993,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,993,1,3,0)
;;=3^Diffuse large B-cell lymphoma, extrnod and solid organ sites
;;^UTILITY(U,$J,358.3,993,1,4,0)
;;=4^C83.39
;;^UTILITY(U,$J,358.3,993,2)
;;=^5001580
;;^UTILITY(U,$J,358.3,994,0)
;;=C81.09^^10^74^62
;;^UTILITY(U,$J,358.3,994,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,994,1,3,0)
;;=3^Nodular lymphocyte predominant Hodgkin lymphoma, extrnod & solid org site
;;^UTILITY(U,$J,358.3,994,1,4,0)
;;=4^C81.09
;;^UTILITY(U,$J,358.3,994,2)
;;=^5001400
;;^UTILITY(U,$J,358.3,995,0)
;;=C81.10^^10^74^63
;;^UTILITY(U,$J,358.3,995,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,995,1,3,0)
;;=3^Nodular sclerosis classical Hodgkin lymphoma, unsp site
;;^UTILITY(U,$J,358.3,995,1,4,0)
;;=4^C81.10
;;^UTILITY(U,$J,358.3,995,2)
;;=^5001401
;;^UTILITY(U,$J,358.3,996,0)
;;=C81.19^^10^74^64
;;^UTILITY(U,$J,358.3,996,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,996,1,3,0)
;;=3^Nodular sclerosis classical Hodgkin lymphoma,extrnod and solid organ sites
;;^UTILITY(U,$J,358.3,996,1,4,0)
;;=4^C81.19
;;^UTILITY(U,$J,358.3,996,2)
;;=^5001410
;;^UTILITY(U,$J,358.3,997,0)
;;=C81.20^^10^74^54
;;^UTILITY(U,$J,358.3,997,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,997,1,3,0)
;;=3^Mixed cellularity classical Hodgkin lymphoma, unsp site
;;^UTILITY(U,$J,358.3,997,1,4,0)
;;=4^C81.20
;;^UTILITY(U,$J,358.3,997,2)
;;=^5001411
;;^UTILITY(U,$J,358.3,998,0)
;;=C81.29^^10^74^53
;;^UTILITY(U,$J,358.3,998,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,998,1,3,0)
;;=3^Mix cellular class Hdgkn lymph, extrnod and solid org sites
;;^UTILITY(U,$J,358.3,998,1,4,0)
;;=4^C81.29
;;^UTILITY(U,$J,358.3,998,2)
;;=^5001420
;;^UTILITY(U,$J,358.3,999,0)
;;=C81.30^^10^74^48
;;^UTILITY(U,$J,358.3,999,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,999,1,3,0)
;;=3^Lymphocyte depleted classical Hodgkin lymphoma, unsp site
;;^UTILITY(U,$J,358.3,999,1,4,0)
;;=4^C81.30
;;^UTILITY(U,$J,358.3,999,2)
;;=^5001421
;;^UTILITY(U,$J,358.3,1000,0)
;;=C81.39^^10^74^47
;;^UTILITY(U,$J,358.3,1000,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1000,1,3,0)
;;=3^Lymphocy deplet class Hdgkn lymph, extrnod & solid org site
;;^UTILITY(U,$J,358.3,1000,1,4,0)
;;=4^C81.39
;;^UTILITY(U,$J,358.3,1000,2)
;;=^5001430
;;^UTILITY(U,$J,358.3,1001,0)
;;=C81.40^^10^74^49
;;^UTILITY(U,$J,358.3,1001,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1001,1,3,0)
;;=3^Lymphocyte-rich classical Hodgkin lymphoma, unspecified site
;;^UTILITY(U,$J,358.3,1001,1,4,0)
;;=4^C81.40
;;^UTILITY(U,$J,358.3,1001,2)
;;=^5001431
;;^UTILITY(U,$J,358.3,1002,0)
;;=C81.49^^10^74^44
;;^UTILITY(U,$J,358.3,1002,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1002,1,3,0)
;;=3^Lymp-rich class Hodgkin lymph, extrnod and solid organ sites
;;^UTILITY(U,$J,358.3,1002,1,4,0)
;;=4^C81.49
;;^UTILITY(U,$J,358.3,1002,2)
;;=^5001440
;;^UTILITY(U,$J,358.3,1003,0)
;;=C81.99^^10^74^42
;;^UTILITY(U,$J,358.3,1003,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1003,1,3,0)
;;=3^Hodgkin lymphoma, unsp, extranodal and solid organ sites
;;^UTILITY(U,$J,358.3,1003,1,4,0)
;;=4^C81.99
;;^UTILITY(U,$J,358.3,1003,2)
;;=^5001460
;;^UTILITY(U,$J,358.3,1004,0)
;;=C81.90^^10^74^43
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI00M 19750 printed Apr 09, 2024@21:20:13 Page 2
IBDEI00M ; ; 01-AUG-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,935,0)
+2 ;;=C22.0^^10^71^4
+3 ;;^UTILITY(U,$J,358.3,935,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,935,1,3,0)
+6 ;;=3^Liver cell carcinoma
+7 ;;^UTILITY(U,$J,358.3,935,1,4,0)
+8 ;;=4^C22.0
+9 ;;^UTILITY(U,$J,358.3,935,2)
+10 ;;=^5000933
+11 ;;^UTILITY(U,$J,358.3,936,0)
+12 ;;=C22.4^^10^71^19
+13 ;;^UTILITY(U,$J,358.3,936,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,936,1,3,0)
+16 ;;=3^Sarcomas of Liver NEC
+17 ;;^UTILITY(U,$J,358.3,936,1,4,0)
+18 ;;=4^C22.4
+19 ;;^UTILITY(U,$J,358.3,936,2)
+20 ;;=^5000937
+21 ;;^UTILITY(U,$J,358.3,937,0)
+22 ;;=C22.3^^10^71^1
+23 ;;^UTILITY(U,$J,358.3,937,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,937,1,3,0)
+26 ;;=3^Angiosarcoma of liver
+27 ;;^UTILITY(U,$J,358.3,937,1,4,0)
+28 ;;=4^C22.3
+29 ;;^UTILITY(U,$J,358.3,937,2)
+30 ;;=^5000936
+31 ;;^UTILITY(U,$J,358.3,938,0)
+32 ;;=C23.^^10^71^11
+33 ;;^UTILITY(U,$J,358.3,938,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,938,1,3,0)
+36 ;;=3^Malignant neoplasm of gallbladder
+37 ;;^UTILITY(U,$J,358.3,938,1,4,0)
+38 ;;=4^C23.
+39 ;;^UTILITY(U,$J,358.3,938,2)
+40 ;;=^267098
+41 ;;^UTILITY(U,$J,358.3,939,0)
+42 ;;=C24.0^^10^71^10
+43 ;;^UTILITY(U,$J,358.3,939,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,939,1,3,0)
+46 ;;=3^Malignant neoplasm of extrahepatic bile duct
+47 ;;^UTILITY(U,$J,358.3,939,1,4,0)
+48 ;;=4^C24.0
+49 ;;^UTILITY(U,$J,358.3,939,2)
+50 ;;=^5000940
+51 ;;^UTILITY(U,$J,358.3,940,0)
+52 ;;=C24.1^^10^71^5
+53 ;;^UTILITY(U,$J,358.3,940,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,940,1,3,0)
+56 ;;=3^Malignant neoplasm of ampulla of Vater
+57 ;;^UTILITY(U,$J,358.3,940,1,4,0)
+58 ;;=4^C24.1
+59 ;;^UTILITY(U,$J,358.3,940,2)
+60 ;;=^267100
+61 ;;^UTILITY(U,$J,358.3,941,0)
+62 ;;=C25.9^^10^71^14
+63 ;;^UTILITY(U,$J,358.3,941,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,941,1,3,0)
+66 ;;=3^Malignant neoplasm of pancreas, unspecified
+67 ;;^UTILITY(U,$J,358.3,941,1,4,0)
+68 ;;=4^C25.9
+69 ;;^UTILITY(U,$J,358.3,941,2)
+70 ;;=^5000946
+71 ;;^UTILITY(U,$J,358.3,942,0)
+72 ;;=C19.^^10^71^15
+73 ;;^UTILITY(U,$J,358.3,942,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,942,1,3,0)
+76 ;;=3^Malignant neoplasm of rectosigmoid junction
+77 ;;^UTILITY(U,$J,358.3,942,1,4,0)
+78 ;;=4^C19.
+79 ;;^UTILITY(U,$J,358.3,942,2)
+80 ;;=^267089
+81 ;;^UTILITY(U,$J,358.3,943,0)
+82 ;;=C24.8^^10^71^13
+83 ;;^UTILITY(U,$J,358.3,943,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,943,1,3,0)
+86 ;;=3^Malignant neoplasm of overlapping sites of biliary tract
+87 ;;^UTILITY(U,$J,358.3,943,1,4,0)
+88 ;;=4^C24.8
+89 ;;^UTILITY(U,$J,358.3,943,2)
+90 ;;=^5000941
+91 ;;^UTILITY(U,$J,358.3,944,0)
+92 ;;=C24.9^^10^71^7
+93 ;;^UTILITY(U,$J,358.3,944,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,944,1,3,0)
+96 ;;=3^Malignant neoplasm of biliary tract,unspec
+97 ;;^UTILITY(U,$J,358.3,944,1,4,0)
+98 ;;=4^C24.9
+99 ;;^UTILITY(U,$J,358.3,944,2)
+100 ;;=^5000942
+101 ;;^UTILITY(U,$J,358.3,945,0)
+102 ;;=C01.^^10^72^2
+103 ;;^UTILITY(U,$J,358.3,945,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,945,1,3,0)
+106 ;;=3^Malignant neoplasm of base of tongue
+107 ;;^UTILITY(U,$J,358.3,945,1,4,0)
+108 ;;=4^C01.
+109 ;;^UTILITY(U,$J,358.3,945,2)
+110 ;;=^266996
+111 ;;^UTILITY(U,$J,358.3,946,0)
+112 ;;=C02.9^^10^72^17
+113 ;;^UTILITY(U,$J,358.3,946,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,946,1,3,0)
+116 ;;=3^Malignant neoplasm of tongue, unspecified
+117 ;;^UTILITY(U,$J,358.3,946,1,4,0)
+118 ;;=4^C02.9
+119 ;;^UTILITY(U,$J,358.3,946,2)
+120 ;;=^5000891
+121 ;;^UTILITY(U,$J,358.3,947,0)
+122 ;;=C04.9^^10^72^3
+123 ;;^UTILITY(U,$J,358.3,947,1,0)
+124 ;;=^358.31IA^4^2
+125 ;;^UTILITY(U,$J,358.3,947,1,3,0)
+126 ;;=3^Malignant neoplasm of floor of mouth, unspecified
+127 ;;^UTILITY(U,$J,358.3,947,1,4,0)
+128 ;;=4^C04.9
+129 ;;^UTILITY(U,$J,358.3,947,2)
+130 ;;=^5000896
+131 ;;^UTILITY(U,$J,358.3,948,0)
+132 ;;=C06.9^^10^72^8
+133 ;;^UTILITY(U,$J,358.3,948,1,0)
+134 ;;=^358.31IA^4^2
+135 ;;^UTILITY(U,$J,358.3,948,1,3,0)
+136 ;;=3^Malignant neoplasm of mouth, unspecified
+137 ;;^UTILITY(U,$J,358.3,948,1,4,0)
+138 ;;=4^C06.9
+139 ;;^UTILITY(U,$J,358.3,948,2)
+140 ;;=^5000901
+141 ;;^UTILITY(U,$J,358.3,949,0)
+142 ;;=C10.9^^10^72^10
+143 ;;^UTILITY(U,$J,358.3,949,1,0)
+144 ;;=^358.31IA^4^2
+145 ;;^UTILITY(U,$J,358.3,949,1,3,0)
+146 ;;=3^Malignant neoplasm of oropharynx, unspecified
+147 ;;^UTILITY(U,$J,358.3,949,1,4,0)
+148 ;;=4^C10.9
+149 ;;^UTILITY(U,$J,358.3,949,2)
+150 ;;=^5000909
+151 ;;^UTILITY(U,$J,358.3,950,0)
+152 ;;=C11.9^^10^72^9
+153 ;;^UTILITY(U,$J,358.3,950,1,0)
+154 ;;=^358.31IA^4^2
+155 ;;^UTILITY(U,$J,358.3,950,1,3,0)
+156 ;;=3^Malignant neoplasm of nasopharynx, unspecified
+157 ;;^UTILITY(U,$J,358.3,950,1,4,0)
+158 ;;=4^C11.9
+159 ;;^UTILITY(U,$J,358.3,950,2)
+160 ;;=^5000911
+161 ;;^UTILITY(U,$J,358.3,951,0)
+162 ;;=C31.9^^10^72^1
+163 ;;^UTILITY(U,$J,358.3,951,1,0)
+164 ;;=^358.31IA^4^2
+165 ;;^UTILITY(U,$J,358.3,951,1,3,0)
+166 ;;=3^Malignant neoplasm of accessory sinus, unspecified
+167 ;;^UTILITY(U,$J,358.3,951,1,4,0)
+168 ;;=4^C31.9
+169 ;;^UTILITY(U,$J,358.3,951,2)
+170 ;;=^5000953
+171 ;;^UTILITY(U,$J,358.3,952,0)
+172 ;;=C32.9^^10^72^6
+173 ;;^UTILITY(U,$J,358.3,952,1,0)
+174 ;;=^358.31IA^4^2
+175 ;;^UTILITY(U,$J,358.3,952,1,3,0)
+176 ;;=3^Malignant neoplasm of larynx, unspecified
+177 ;;^UTILITY(U,$J,358.3,952,1,4,0)
+178 ;;=4^C32.9
+179 ;;^UTILITY(U,$J,358.3,952,2)
+180 ;;=^5000956
+181 ;;^UTILITY(U,$J,358.3,953,0)
+182 ;;=C33.^^10^72^19
+183 ;;^UTILITY(U,$J,358.3,953,1,0)
+184 ;;=^358.31IA^4^2
+185 ;;^UTILITY(U,$J,358.3,953,1,3,0)
+186 ;;=3^Malignant neoplasm of trachea
+187 ;;^UTILITY(U,$J,358.3,953,1,4,0)
+188 ;;=4^C33.
+189 ;;^UTILITY(U,$J,358.3,953,2)
+190 ;;=^267135
+191 ;;^UTILITY(U,$J,358.3,954,0)
+192 ;;=C34.91^^10^72^21
+193 ;;^UTILITY(U,$J,358.3,954,1,0)
+194 ;;=^358.31IA^4^2
+195 ;;^UTILITY(U,$J,358.3,954,1,3,0)
+196 ;;=3^Malignant neoplasm of unsp part of right bronchus or lung
+197 ;;^UTILITY(U,$J,358.3,954,1,4,0)
+198 ;;=4^C34.91
+199 ;;^UTILITY(U,$J,358.3,954,2)
+200 ;;=^5000967
+201 ;;^UTILITY(U,$J,358.3,955,0)
+202 ;;=C34.92^^10^72^20
+203 ;;^UTILITY(U,$J,358.3,955,1,0)
+204 ;;=^358.31IA^4^2
+205 ;;^UTILITY(U,$J,358.3,955,1,3,0)
+206 ;;=3^Malignant neoplasm of unsp part of left bronchus or lung
+207 ;;^UTILITY(U,$J,358.3,955,1,4,0)
+208 ;;=4^C34.92
+209 ;;^UTILITY(U,$J,358.3,955,2)
+210 ;;=^5000968
+211 ;;^UTILITY(U,$J,358.3,956,0)
+212 ;;=C38.4^^10^72^14
+213 ;;^UTILITY(U,$J,358.3,956,1,0)
+214 ;;=^358.31IA^4^2
+215 ;;^UTILITY(U,$J,358.3,956,1,3,0)
+216 ;;=3^Malignant neoplasm of pleura
+217 ;;^UTILITY(U,$J,358.3,956,1,4,0)
+218 ;;=4^C38.4
+219 ;;^UTILITY(U,$J,358.3,956,2)
+220 ;;=^267140
+221 ;;^UTILITY(U,$J,358.3,957,0)
+222 ;;=C45.0^^10^72^22
+223 ;;^UTILITY(U,$J,358.3,957,1,0)
+224 ;;=^358.31IA^4^2
+225 ;;^UTILITY(U,$J,358.3,957,1,3,0)
+226 ;;=3^Mesothelioma of pleura
+227 ;;^UTILITY(U,$J,358.3,957,1,4,0)
+228 ;;=4^C45.0
+229 ;;^UTILITY(U,$J,358.3,957,2)
+230 ;;=^5001095
+231 ;;^UTILITY(U,$J,358.3,958,0)
+232 ;;=C73.^^10^72^16
+233 ;;^UTILITY(U,$J,358.3,958,1,0)
+234 ;;=^358.31IA^4^2
+235 ;;^UTILITY(U,$J,358.3,958,1,3,0)
+236 ;;=3^Malignant neoplasm of thyroid gland
+237 ;;^UTILITY(U,$J,358.3,958,1,4,0)
+238 ;;=4^C73.
+239 ;;^UTILITY(U,$J,358.3,958,2)
+240 ;;=^267296
+241 ;;^UTILITY(U,$J,358.3,959,0)
+242 ;;=C76.0^^10^72^4
+243 ;;^UTILITY(U,$J,358.3,959,1,0)
+244 ;;=^358.31IA^4^2
+245 ;;^UTILITY(U,$J,358.3,959,1,3,0)
+246 ;;=3^Malignant neoplasm of head, face and neck
+247 ;;^UTILITY(U,$J,358.3,959,1,4,0)
+248 ;;=4^C76.0
+249 ;;^UTILITY(U,$J,358.3,959,2)
+250 ;;=^5001324
+251 ;;^UTILITY(U,$J,358.3,960,0)
+252 ;;=C05.9^^10^72^11
+253 ;;^UTILITY(U,$J,358.3,960,1,0)
+254 ;;=^358.31IA^4^2
+255 ;;^UTILITY(U,$J,358.3,960,1,3,0)
+256 ;;=3^Malignant neoplasm of palate,unspec
+257 ;;^UTILITY(U,$J,358.3,960,1,4,0)
+258 ;;=4^C05.9
+259 ;;^UTILITY(U,$J,358.3,960,2)
+260 ;;=^5000898
+261 ;;^UTILITY(U,$J,358.3,961,0)
+262 ;;=C07.^^10^72^12
+263 ;;^UTILITY(U,$J,358.3,961,1,0)
+264 ;;=^358.31IA^4^2
+265 ;;^UTILITY(U,$J,358.3,961,1,3,0)
+266 ;;=3^Malignant neoplasm of parotid gland
+267 ;;^UTILITY(U,$J,358.3,961,1,4,0)
+268 ;;=4^C07.
+269 ;;^UTILITY(U,$J,358.3,961,2)
+270 ;;=^267005
+271 ;;^UTILITY(U,$J,358.3,962,0)
+272 ;;=C08.9^^10^72^7
+273 ;;^UTILITY(U,$J,358.3,962,1,0)
+274 ;;=^358.31IA^4^2
+275 ;;^UTILITY(U,$J,358.3,962,1,3,0)
+276 ;;=3^Malignant neoplasm of major salivary gland,unspec
+277 ;;^UTILITY(U,$J,358.3,962,1,4,0)
+278 ;;=4^C08.9
+279 ;;^UTILITY(U,$J,358.3,962,2)
+280 ;;=^5000902
+281 ;;^UTILITY(U,$J,358.3,963,0)
+282 ;;=C09.9^^10^72^18
+283 ;;^UTILITY(U,$J,358.3,963,1,0)
+284 ;;=^358.31IA^4^2
+285 ;;^UTILITY(U,$J,358.3,963,1,3,0)
+286 ;;=3^Malignant neoplasm of tonsil,unspec
+287 ;;^UTILITY(U,$J,358.3,963,1,4,0)
+288 ;;=4^C09.9
+289 ;;^UTILITY(U,$J,358.3,963,2)
+290 ;;=^5000905
+291 ;;^UTILITY(U,$J,358.3,964,0)
+292 ;;=C12.^^10^72^15
+293 ;;^UTILITY(U,$J,358.3,964,1,0)
+294 ;;=^358.31IA^4^2
+295 ;;^UTILITY(U,$J,358.3,964,1,3,0)
+296 ;;=3^Malignant neoplasm of pyriform sinus
+297 ;;^UTILITY(U,$J,358.3,964,1,4,0)
+298 ;;=4^C12.
+299 ;;^UTILITY(U,$J,358.3,964,2)
+300 ;;=^267046
+301 ;;^UTILITY(U,$J,358.3,965,0)
+302 ;;=C13.9^^10^72^5
+303 ;;^UTILITY(U,$J,358.3,965,1,0)
+304 ;;=^358.31IA^4^2
+305 ;;^UTILITY(U,$J,358.3,965,1,3,0)
+306 ;;=3^Malignant neoplasm of hypopharynx,unspec
+307 ;;^UTILITY(U,$J,358.3,965,1,4,0)
+308 ;;=4^C13.9
+309 ;;^UTILITY(U,$J,358.3,965,2)
+310 ;;=^5000915
+311 ;;^UTILITY(U,$J,358.3,966,0)
+312 ;;=C14.0^^10^72^13
+313 ;;^UTILITY(U,$J,358.3,966,1,0)
+314 ;;=^358.31IA^4^2
+315 ;;^UTILITY(U,$J,358.3,966,1,3,0)
+316 ;;=3^Malignant neoplasm of pharynx,unspec
+317 ;;^UTILITY(U,$J,358.3,966,1,4,0)
+318 ;;=4^C14.0
+319 ;;^UTILITY(U,$J,358.3,966,2)
+320 ;;=^5000916
+321 ;;^UTILITY(U,$J,358.3,967,0)
+322 ;;=D57.40^^10^73^15
+323 ;;^UTILITY(U,$J,358.3,967,1,0)
+324 ;;=^358.31IA^4^2
+325 ;;^UTILITY(U,$J,358.3,967,1,3,0)
+326 ;;=3^Sickle-cell thalassemia without crisis
+327 ;;^UTILITY(U,$J,358.3,967,1,4,0)
+328 ;;=4^D57.40
+329 ;;^UTILITY(U,$J,358.3,967,2)
+330 ;;=^329908
+331 ;;^UTILITY(U,$J,358.3,968,0)
+332 ;;=D57.419^^10^73^14
+333 ;;^UTILITY(U,$J,358.3,968,1,0)
+334 ;;=^358.31IA^4^2
+335 ;;^UTILITY(U,$J,358.3,968,1,3,0)
+336 ;;=3^Sickle-cell thalassemia with crisis, unspecified
+337 ;;^UTILITY(U,$J,358.3,968,1,4,0)
+338 ;;=4^D57.419
+339 ;;^UTILITY(U,$J,358.3,968,2)
+340 ;;=^5002316
+341 ;;^UTILITY(U,$J,358.3,969,0)
+342 ;;=D56.0^^10^73^1
+343 ;;^UTILITY(U,$J,358.3,969,1,0)
+344 ;;=^358.31IA^4^2
+345 ;;^UTILITY(U,$J,358.3,969,1,3,0)
+346 ;;=3^Alpha thalassemia
+347 ;;^UTILITY(U,$J,358.3,969,1,4,0)
+348 ;;=4^D56.0
+349 ;;^UTILITY(U,$J,358.3,969,2)
+350 ;;=^340494
+351 ;;^UTILITY(U,$J,358.3,970,0)
+352 ;;=D56.1^^10^73^2
+353 ;;^UTILITY(U,$J,358.3,970,1,0)
+354 ;;=^358.31IA^4^2
+355 ;;^UTILITY(U,$J,358.3,970,1,3,0)
+356 ;;=3^Beta thalassemia
+357 ;;^UTILITY(U,$J,358.3,970,1,4,0)
+358 ;;=4^D56.1
+359 ;;^UTILITY(U,$J,358.3,970,2)
+360 ;;=^340495
+361 ;;^UTILITY(U,$J,358.3,971,0)
+362 ;;=D56.2^^10^73^3
+363 ;;^UTILITY(U,$J,358.3,971,1,0)
+364 ;;=^358.31IA^4^2
+365 ;;^UTILITY(U,$J,358.3,971,1,3,0)
+366 ;;=3^Delta-beta thalassemia
+367 ;;^UTILITY(U,$J,358.3,971,1,4,0)
+368 ;;=4^D56.2
+369 ;;^UTILITY(U,$J,358.3,971,2)
+370 ;;=^340496
+371 ;;^UTILITY(U,$J,358.3,972,0)
+372 ;;=D56.3^^10^73^18
+373 ;;^UTILITY(U,$J,358.3,972,1,0)
+374 ;;=^358.31IA^4^2
+375 ;;^UTILITY(U,$J,358.3,972,1,3,0)
+376 ;;=3^Thalassemia minor
+377 ;;^UTILITY(U,$J,358.3,972,1,4,0)
+378 ;;=4^D56.3
+379 ;;^UTILITY(U,$J,358.3,972,2)
+380 ;;=^340497
+381 ;;^UTILITY(U,$J,358.3,973,0)
+382 ;;=D56.5^^10^73^7
+383 ;;^UTILITY(U,$J,358.3,973,1,0)
+384 ;;=^358.31IA^4^2
+385 ;;^UTILITY(U,$J,358.3,973,1,3,0)
+386 ;;=3^Hemoglobin E-beta thalassemia
+387 ;;^UTILITY(U,$J,358.3,973,1,4,0)
+388 ;;=4^D56.5
+389 ;;^UTILITY(U,$J,358.3,973,2)
+390 ;;=^340498
+391 ;;^UTILITY(U,$J,358.3,974,0)
+392 ;;=D56.8^^10^73^19
+393 ;;^UTILITY(U,$J,358.3,974,1,0)
+394 ;;=^358.31IA^4^2
+395 ;;^UTILITY(U,$J,358.3,974,1,3,0)
+396 ;;=3^Thalassemias NEC
+397 ;;^UTILITY(U,$J,358.3,974,1,4,0)
+398 ;;=4^D56.8
+399 ;;^UTILITY(U,$J,358.3,974,2)
+400 ;;=^5002305
+401 ;;^UTILITY(U,$J,358.3,975,0)
+402 ;;=D57.3^^10^73^16
+403 ;;^UTILITY(U,$J,358.3,975,1,0)
+404 ;;=^358.31IA^4^2
+405 ;;^UTILITY(U,$J,358.3,975,1,3,0)
+406 ;;=3^Sickle-cell trait
+407 ;;^UTILITY(U,$J,358.3,975,1,4,0)
+408 ;;=4^D57.3
+409 ;;^UTILITY(U,$J,358.3,975,2)
+410 ;;=^5002313
+411 ;;^UTILITY(U,$J,358.3,976,0)
+412 ;;=D57.1^^10^73^13
+413 ;;^UTILITY(U,$J,358.3,976,1,0)
+414 ;;=^358.31IA^4^2
+415 ;;^UTILITY(U,$J,358.3,976,1,3,0)
+416 ;;=3^Sickle-cell disease without crisis
+417 ;;^UTILITY(U,$J,358.3,976,1,4,0)
+418 ;;=4^D57.1
+419 ;;^UTILITY(U,$J,358.3,976,2)
+420 ;;=^5002309
+421 ;;^UTILITY(U,$J,358.3,977,0)
+422 ;;=D57.02^^10^73^6
+423 ;;^UTILITY(U,$J,358.3,977,1,0)
+424 ;;=^358.31IA^4^2
+425 ;;^UTILITY(U,$J,358.3,977,1,3,0)
+426 ;;=3^Hb-SS disease with splenic sequestration
+427 ;;^UTILITY(U,$J,358.3,977,1,4,0)
+428 ;;=4^D57.02
+429 ;;^UTILITY(U,$J,358.3,977,2)
+430 ;;=^5002308
+431 ;;^UTILITY(U,$J,358.3,978,0)
+432 ;;=D57.01^^10^73^4
+433 ;;^UTILITY(U,$J,358.3,978,1,0)
+434 ;;=^358.31IA^4^2
+435 ;;^UTILITY(U,$J,358.3,978,1,3,0)
+436 ;;=3^Hb-SS disease with acute chest syndrome
+437 ;;^UTILITY(U,$J,358.3,978,1,4,0)
+438 ;;=4^D57.01
+439 ;;^UTILITY(U,$J,358.3,978,2)
+440 ;;=^5002307
+441 ;;^UTILITY(U,$J,358.3,979,0)
+442 ;;=D57.00^^10^73^5
+443 ;;^UTILITY(U,$J,358.3,979,1,0)
+444 ;;=^358.31IA^4^2
+445 ;;^UTILITY(U,$J,358.3,979,1,3,0)
+446 ;;=3^Hb-SS disease with crisis, unspecified
+447 ;;^UTILITY(U,$J,358.3,979,1,4,0)
+448 ;;=4^D57.00
+449 ;;^UTILITY(U,$J,358.3,979,2)
+450 ;;=^5002306
+451 ;;^UTILITY(U,$J,358.3,980,0)
+452 ;;=D57.20^^10^73^17
+453 ;;^UTILITY(U,$J,358.3,980,1,0)
+454 ;;=^358.31IA^4^2
+455 ;;^UTILITY(U,$J,358.3,980,1,3,0)
+456 ;;=3^Sickle-cell/Hb-C disease without crisis
+457 ;;^UTILITY(U,$J,358.3,980,1,4,0)
+458 ;;=4^D57.20
+459 ;;^UTILITY(U,$J,358.3,980,2)
+460 ;;=^330080
+461 ;;^UTILITY(U,$J,358.3,981,0)
+462 ;;=D57.811^^10^73^10
+463 ;;^UTILITY(U,$J,358.3,981,1,0)
+464 ;;=^358.31IA^4^2
+465 ;;^UTILITY(U,$J,358.3,981,1,3,0)
+466 ;;=3^Sickle-Cell Disorders w/ Acute Chest Syndrome NEC
+467 ;;^UTILITY(U,$J,358.3,981,1,4,0)
+468 ;;=4^D57.811
+469 ;;^UTILITY(U,$J,358.3,981,2)
+470 ;;=^5002318
+471 ;;^UTILITY(U,$J,358.3,982,0)
+472 ;;=D57.812^^10^73^11
+473 ;;^UTILITY(U,$J,358.3,982,1,0)
+474 ;;=^358.31IA^4^2
+475 ;;^UTILITY(U,$J,358.3,982,1,3,0)
+476 ;;=3^Sickle-Cell Disorders w/ Splenic Sequestration
+477 ;;^UTILITY(U,$J,358.3,982,1,4,0)
+478 ;;=4^D57.812
+479 ;;^UTILITY(U,$J,358.3,982,2)
+480 ;;=^5002319
+481 ;;^UTILITY(U,$J,358.3,983,0)
+482 ;;=D57.819^^10^73^12
+483 ;;^UTILITY(U,$J,358.3,983,1,0)
+484 ;;=^358.31IA^4^2
+485 ;;^UTILITY(U,$J,358.3,983,1,3,0)
+486 ;;=3^Sickle-Cell Disorders w/ Unspec Crisis NEC
+487 ;;^UTILITY(U,$J,358.3,983,1,4,0)
+488 ;;=4^D57.819
+489 ;;^UTILITY(U,$J,358.3,983,2)
+490 ;;=^5002320
+491 ;;^UTILITY(U,$J,358.3,984,0)
+492 ;;=D58.8^^10^73^9
+493 ;;^UTILITY(U,$J,358.3,984,1,0)
+494 ;;=^358.31IA^4^2
+495 ;;^UTILITY(U,$J,358.3,984,1,3,0)
+496 ;;=3^Hereditary Hemolytic Anemias NEC
+497 ;;^UTILITY(U,$J,358.3,984,1,4,0)
+498 ;;=4^D58.8
+499 ;;^UTILITY(U,$J,358.3,984,2)
+500 ;;=^267984
+501 ;;^UTILITY(U,$J,358.3,985,0)
+502 ;;=D58.2^^10^73^8
+503 ;;^UTILITY(U,$J,358.3,985,1,0)
+504 ;;=^358.31IA^4^2
+505 ;;^UTILITY(U,$J,358.3,985,1,3,0)
+506 ;;=3^Hemoglobinopathies NEC
+507 ;;^UTILITY(U,$J,358.3,985,1,4,0)
+508 ;;=4^D58.2
+509 ;;^UTILITY(U,$J,358.3,985,2)
+510 ;;=^87629
+511 ;;^UTILITY(U,$J,358.3,986,0)
+512 ;;=C83.10^^10^74^52
+513 ;;^UTILITY(U,$J,358.3,986,1,0)
+514 ;;=^358.31IA^4^2
+515 ;;^UTILITY(U,$J,358.3,986,1,3,0)
+516 ;;=3^Mantle cell lymphoma, unspecified site
+517 ;;^UTILITY(U,$J,358.3,986,1,4,0)
+518 ;;=4^C83.10
+519 ;;^UTILITY(U,$J,358.3,986,2)
+520 ;;=^5001561
+521 ;;^UTILITY(U,$J,358.3,987,0)
+522 ;;=C83.19^^10^74^51
+523 ;;^UTILITY(U,$J,358.3,987,1,0)
+524 ;;=^358.31IA^4^2
+525 ;;^UTILITY(U,$J,358.3,987,1,3,0)
+526 ;;=3^Mantle cell lymphoma, extranodal and solid organ sites
+527 ;;^UTILITY(U,$J,358.3,987,1,4,0)
+528 ;;=4^C83.19
+529 ;;^UTILITY(U,$J,358.3,987,2)
+530 ;;=^5001570
+531 ;;^UTILITY(U,$J,358.3,988,0)
+532 ;;=C83.50^^10^74^45
+533 ;;^UTILITY(U,$J,358.3,988,1,0)
+534 ;;=^358.31IA^4^2
+535 ;;^UTILITY(U,$J,358.3,988,1,3,0)
+536 ;;=3^Lymphoblastic (diffuse) lymphoma, unspecified site
+537 ;;^UTILITY(U,$J,358.3,988,1,4,0)
+538 ;;=4^C83.50
+539 ;;^UTILITY(U,$J,358.3,988,2)
+540 ;;=^5001581
+541 ;;^UTILITY(U,$J,358.3,989,0)
+542 ;;=C83.59^^10^74^46
+543 ;;^UTILITY(U,$J,358.3,989,1,0)
+544 ;;=^358.31IA^4^2
+545 ;;^UTILITY(U,$J,358.3,989,1,3,0)
+546 ;;=3^Lymphoblastic lymphoma, extrnod and solid organ sites
+547 ;;^UTILITY(U,$J,358.3,989,1,4,0)
+548 ;;=4^C83.59
+549 ;;^UTILITY(U,$J,358.3,989,2)
+550 ;;=^5001590
+551 ;;^UTILITY(U,$J,358.3,990,0)
+552 ;;=C83.70^^10^74^12
+553 ;;^UTILITY(U,$J,358.3,990,1,0)
+554 ;;=^358.31IA^4^2
+555 ;;^UTILITY(U,$J,358.3,990,1,3,0)
+556 ;;=3^Burkitt lymphoma, unspecified site
+557 ;;^UTILITY(U,$J,358.3,990,1,4,0)
+558 ;;=4^C83.70
+559 ;;^UTILITY(U,$J,358.3,990,2)
+560 ;;=^5001591
+561 ;;^UTILITY(U,$J,358.3,991,0)
+562 ;;=C83.79^^10^74^11
+563 ;;^UTILITY(U,$J,358.3,991,1,0)
+564 ;;=^358.31IA^4^2
+565 ;;^UTILITY(U,$J,358.3,991,1,3,0)
+566 ;;=3^Burkitt lymphoma, extranodal and solid organ sites
+567 ;;^UTILITY(U,$J,358.3,991,1,4,0)
+568 ;;=4^C83.79
+569 ;;^UTILITY(U,$J,358.3,991,2)
+570 ;;=^5001600
+571 ;;^UTILITY(U,$J,358.3,992,0)
+572 ;;=C81.00^^10^74^61
+573 ;;^UTILITY(U,$J,358.3,992,1,0)
+574 ;;=^358.31IA^4^2
+575 ;;^UTILITY(U,$J,358.3,992,1,3,0)
+576 ;;=3^Nodular lymphocyte predominant Hodgkin lymphoma, unsp site
+577 ;;^UTILITY(U,$J,358.3,992,1,4,0)
+578 ;;=4^C81.00
+579 ;;^UTILITY(U,$J,358.3,992,2)
+580 ;;=^5001391
+581 ;;^UTILITY(U,$J,358.3,993,0)
+582 ;;=C83.39^^10^74^22
+583 ;;^UTILITY(U,$J,358.3,993,1,0)
+584 ;;=^358.31IA^4^2
+585 ;;^UTILITY(U,$J,358.3,993,1,3,0)
+586 ;;=3^Diffuse large B-cell lymphoma, extrnod and solid organ sites
+587 ;;^UTILITY(U,$J,358.3,993,1,4,0)
+588 ;;=4^C83.39
+589 ;;^UTILITY(U,$J,358.3,993,2)
+590 ;;=^5001580
+591 ;;^UTILITY(U,$J,358.3,994,0)
+592 ;;=C81.09^^10^74^62
+593 ;;^UTILITY(U,$J,358.3,994,1,0)
+594 ;;=^358.31IA^4^2
+595 ;;^UTILITY(U,$J,358.3,994,1,3,0)
+596 ;;=3^Nodular lymphocyte predominant Hodgkin lymphoma, extrnod & solid org site
+597 ;;^UTILITY(U,$J,358.3,994,1,4,0)
+598 ;;=4^C81.09
+599 ;;^UTILITY(U,$J,358.3,994,2)
+600 ;;=^5001400
+601 ;;^UTILITY(U,$J,358.3,995,0)
+602 ;;=C81.10^^10^74^63
+603 ;;^UTILITY(U,$J,358.3,995,1,0)
+604 ;;=^358.31IA^4^2
+605 ;;^UTILITY(U,$J,358.3,995,1,3,0)
+606 ;;=3^Nodular sclerosis classical Hodgkin lymphoma, unsp site
+607 ;;^UTILITY(U,$J,358.3,995,1,4,0)
+608 ;;=4^C81.10
+609 ;;^UTILITY(U,$J,358.3,995,2)
+610 ;;=^5001401
+611 ;;^UTILITY(U,$J,358.3,996,0)
+612 ;;=C81.19^^10^74^64
+613 ;;^UTILITY(U,$J,358.3,996,1,0)
+614 ;;=^358.31IA^4^2
+615 ;;^UTILITY(U,$J,358.3,996,1,3,0)
+616 ;;=3^Nodular sclerosis classical Hodgkin lymphoma,extrnod and solid organ sites
+617 ;;^UTILITY(U,$J,358.3,996,1,4,0)
+618 ;;=4^C81.19
+619 ;;^UTILITY(U,$J,358.3,996,2)
+620 ;;=^5001410
+621 ;;^UTILITY(U,$J,358.3,997,0)
+622 ;;=C81.20^^10^74^54
+623 ;;^UTILITY(U,$J,358.3,997,1,0)
+624 ;;=^358.31IA^4^2
+625 ;;^UTILITY(U,$J,358.3,997,1,3,0)
+626 ;;=3^Mixed cellularity classical Hodgkin lymphoma, unsp site
+627 ;;^UTILITY(U,$J,358.3,997,1,4,0)
+628 ;;=4^C81.20
+629 ;;^UTILITY(U,$J,358.3,997,2)
+630 ;;=^5001411
+631 ;;^UTILITY(U,$J,358.3,998,0)
+632 ;;=C81.29^^10^74^53
+633 ;;^UTILITY(U,$J,358.3,998,1,0)
+634 ;;=^358.31IA^4^2
+635 ;;^UTILITY(U,$J,358.3,998,1,3,0)
+636 ;;=3^Mix cellular class Hdgkn lymph, extrnod and solid org sites
+637 ;;^UTILITY(U,$J,358.3,998,1,4,0)
+638 ;;=4^C81.29
+639 ;;^UTILITY(U,$J,358.3,998,2)
+640 ;;=^5001420
+641 ;;^UTILITY(U,$J,358.3,999,0)
+642 ;;=C81.30^^10^74^48
+643 ;;^UTILITY(U,$J,358.3,999,1,0)
+644 ;;=^358.31IA^4^2
+645 ;;^UTILITY(U,$J,358.3,999,1,3,0)
+646 ;;=3^Lymphocyte depleted classical Hodgkin lymphoma, unsp site
+647 ;;^UTILITY(U,$J,358.3,999,1,4,0)
+648 ;;=4^C81.30
+649 ;;^UTILITY(U,$J,358.3,999,2)
+650 ;;=^5001421
+651 ;;^UTILITY(U,$J,358.3,1000,0)
+652 ;;=C81.39^^10^74^47
+653 ;;^UTILITY(U,$J,358.3,1000,1,0)
+654 ;;=^358.31IA^4^2
+655 ;;^UTILITY(U,$J,358.3,1000,1,3,0)
+656 ;;=3^Lymphocy deplet class Hdgkn lymph, extrnod & solid org site
+657 ;;^UTILITY(U,$J,358.3,1000,1,4,0)
+658 ;;=4^C81.39
+659 ;;^UTILITY(U,$J,358.3,1000,2)
+660 ;;=^5001430
+661 ;;^UTILITY(U,$J,358.3,1001,0)
+662 ;;=C81.40^^10^74^49
+663 ;;^UTILITY(U,$J,358.3,1001,1,0)
+664 ;;=^358.31IA^4^2
+665 ;;^UTILITY(U,$J,358.3,1001,1,3,0)
+666 ;;=3^Lymphocyte-rich classical Hodgkin lymphoma, unspecified site
+667 ;;^UTILITY(U,$J,358.3,1001,1,4,0)
+668 ;;=4^C81.40
+669 ;;^UTILITY(U,$J,358.3,1001,2)
+670 ;;=^5001431
+671 ;;^UTILITY(U,$J,358.3,1002,0)
+672 ;;=C81.49^^10^74^44
+673 ;;^UTILITY(U,$J,358.3,1002,1,0)
+674 ;;=^358.31IA^4^2
+675 ;;^UTILITY(U,$J,358.3,1002,1,3,0)
+676 ;;=3^Lymp-rich class Hodgkin lymph, extrnod and solid organ sites
+677 ;;^UTILITY(U,$J,358.3,1002,1,4,0)
+678 ;;=4^C81.49
+679 ;;^UTILITY(U,$J,358.3,1002,2)
+680 ;;=^5001440
+681 ;;^UTILITY(U,$J,358.3,1003,0)
+682 ;;=C81.99^^10^74^42
+683 ;;^UTILITY(U,$J,358.3,1003,1,0)
+684 ;;=^358.31IA^4^2
+685 ;;^UTILITY(U,$J,358.3,1003,1,3,0)
+686 ;;=3^Hodgkin lymphoma, unsp, extranodal and solid organ sites
+687 ;;^UTILITY(U,$J,358.3,1003,1,4,0)
+688 ;;=4^C81.99
+689 ;;^UTILITY(U,$J,358.3,1003,2)
+690 ;;=^5001460
+691 ;;^UTILITY(U,$J,358.3,1004,0)
+692 ;;=C81.90^^10^74^43
